Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Scaltriti, Maurizio; Rojo, Federico; Ocana, Alberto; Anido, Judit; Guzman, Marta; Cortes, Javier; Di Cosimo, Serena; Matias-Guiu, Xavier; Ramon y Cajal, Santiago; Arribas, Joaquin; Baselga, Jose

    Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 99 628-638. .

    [doi:10.1093/jnci/djk134]

  • Vidal, David; Matias-Guiu, Xavier; Alomar, Agustin

    Fifty-five basal cell carcinomas treated with topical imiquimod: Outcome at 5-year follow-up

    ARCH DERMATOL 143 266-268. .

    [doi:10.1001/archderm.143.2.266]

  • Velasco, Ana; Bussaglia, Elena; Pallares, Judit; Dolcet, Xavier; Llobet, David; Encinas, Mario; Llecha, Nuria; Palacios, Jose; Prat, Jaime; Matias-Guiu, Xavier

    PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

    HUMAN PATHOLOGY 37 1465-1472. .

    [doi:10.1016/j.humpath.2006.05.007]

  • Dolcet, Xavier; Llobet, David; Encinas, Mario; Pallares, Judit; Cabero, Albert; Schoenenberger, Joan Antoni; Comella, Joan X.; Matias-Guiu, Xavier

    Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants.

    Journal Of Biological Chemistry 281 22118-22130. .

    [doi:10.1074/jbc.M601350200]

  • Mayorga, ME; Sanchis, D; De Santos, AMP; Velasco, A; Dolcet, X; Casanova, JM; Baradad, M; Egido, R; Pallares, J; Espurz, N; Benitez, D; Mila, J; Malvehy, J; Castel, T; Comella, JX; Matias-Guiu, X; Vilella, R; Marti, RM

    Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines.

    MELANOMA RESEARCH 16 127-135. .

    [doi:10.1097/01.cmr.0000215039.30812.9b]

  • Alvarez-Nunez, F; Bussaglia, E; Mauricio, D; Ybarra, J; Vilar, M; Lerma, E; de Leiva, A; Matias-Guju, X

    PTEN promoter methylation in sporadic thyroid carcinomas.

    Thyroid 16 17-23. .

    [doi:10.1089/thy.2006.16.17]

  • Domingo, P; Vidal, F; Domingo, JC; Veloso, S; Sambeat, MA; Torres, F; Sirvent, JJ; Vendrell, J; Matias-Guiu, X; Richart, C

    Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 35 771-780. .

    [doi:10.1111/j.1365-2362.2005.01576.x]

  • Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X

    Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

  • Dolcet, X; Llobet, D; Pallares, J; Rue, M; Comella, JX; Matias-Guiu, X

    FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.

    LABORATORY INVESTIGATION 85 885-894. .

    [doi:10.1038/labinvest.3700286]

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Survivin expression in endometrial carcinoma - a tissue microarray study with correlation with PTEN and STaT-3

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

    [doi:10.1097/01.pgp.0000163849.37129.d4]

  • Velasco, A; Palomar-Asenjo, V; Ganan, L; Catasus, L; Llecha, N; Panizo, A; Palomar-Garcia, V; Quer, M; Matias-Guiu, X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma - Description of one novel germline mutation

    Diagnostic Molecular Pathology 14 109-114. .

    [doi:10.1097/01.pas.0000158987.07907.7e]

  • Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.

    Diagnostic Molecular Pathology 14 109-114. .

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU